Navigation Links
Kendle Appoints J. Michael Sprafka, MPH, PhD, Vice President, Kendle Consulting
Date:11/2/2009

CINCINNATI, Nov. 2 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced the appointment of J. Michael Sprafka, MPH, PhD, as Vice President, Kendle Consulting. Dr. Sprafka will provide leadership for and drive the development of integrated product development consulting services to help biopharmaceutical companies accelerate time to market and maximize the long-term commercial value of their products. His focus will be on delivery of best-in-class consulting services for customers in the areas of regulatory affairs and submissions, risk management, epidemiology, pharmacovigilance, signal detection and safety evaluations, among others. Dr. Sprafka has held senior leadership roles in the pharmaceutical and government sectors as well as academia and brings the executive level leadership and analytical expertise needed to meet increasing customer demands and heightened global regulatory requirements. He will be based out of Kendle's global headquarters in Cincinnati and will report to Melanie Bruno, PhD, MBA, Vice President, Regulatory, Site and Medical Affairs.

"I am delighted to welcome Michael to the Kendle team," said Dr. Bruno. "His extensive and diverse experience will significantly enhance our ability to deliver best-in-class regulatory consulting services and risk management capabilities to our customers across Phase I through IV clinical development and beyond. As our customers' products move through the product life cycle, Kendle's Consulting team can assist in conducting sophisticated analyses from ongoing data sources to gain a greater understanding of side effects and adverse events and best reflect the products' safety for the patient."

The addition of Dr. Sprafka strengthens Kendle Consulting, a growing area of the Company dedicated to working with biopharmaceutical companies to optimize their clinical development planning, understand and minimize risk and manage product development and monitoring throughout the product lifecycle. By combining the cumulative expertise of Kendle's broad spectrum of clinical development services, Kendle Consulting matches thought leadership with the specific needs of our customers to maximize the value of their portfolios.

Dr. Sprafka is an epidemiologist with extensive expertise in pharmacovigilance, outcomes research and pharmacoeconomics. He has more than 15 years of senior leadership experience, having served most recently as Senior Director, Pharmacovigilance, Epidemiology and Pharmacoeconomics for Procter & Gamble Pharmaceuticals. Dr. Sprafka also has served as Associate Professor of Epidemiology at the University of Minnesota and as an Epidemiologist at the Minnesota Department of Health. He holds a Bachelor of Arts in biology, a Master of Science in environmental health, a Master of Public Health in epidemiology and a Doctorate in epidemiology from the University of Minnesota.

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the world's largest global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 500, Cincinnati, OH 45202 or from the Company's Web site at www.kendle.com.

SOURCE Kendle International Inc.


'/>"/>
SOURCE Kendle International Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Kendle Announces Details Regarding Third Quarter 2009 Earnings Conference Call and Webcast
2. Kendle Experts to Share Insights at the Regulatory Affairs Professionals Society Annual Conference and Exhibition
3. Kendle Experts to Present at the Drug Information Association 44th Annual Meeting
4. Qforma Appoints Erin McLaughlin as Director, Field Operations
5. VitaminSpice Appoints Dr. Richard F. Seelig as Director
6. Santaris Pharma A/S Expands Executive Team, Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA-targeted Drug Development Programs
7. NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
8. Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs
9. Takeda San Francisco, Inc. Appoints Michael Buckley, Ph.D. Vice President of Process Sciences
10. EUCODIS Bioscience Appoints Bhupinder Hundle to Senior Vice President Marketing & Sales
11. Dynatronics Appoints Douglas Sampson as Vice President of Production and Research & Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... 11, 2017  Caris Life Sciences ® , a ... promise of precision medicine, today announced that St. Jude ... Oncology Alliance™ (POA) as its 17 th member. ... Jude Crosson Cancer Institute will help develop standards of ... tumor profiling, making cancer treatment more precise and effective. ...
(Date:10/10/2017)... , Oct. 10, 2017   West Pharmaceutical Services, ... solutions for injectable drug administration, today shared the results ... Adapter for improving the intradermal administration of polio vaccines. ... Vaccination Summit in May 2017 by Dr. Ondrej ... Department, World Health Organization (WHO), and recently published in ...
(Date:10/4/2017)... 4, 2017  According to the Centers for Disease Control and Prevention ... . PhysicianOne Urgent Care is helping communities across Massachusetts ... , by offering no-cost* flu shots through the end of the month. ... health insurance regulations. ... to get a flu shot is by the end of October, according ...
Breaking Medicine Technology:
(Date:10/12/2017)... WILMINGTON, Del. (PRWEB) , ... October 12, 2017 ... ... technology and advisory services for healthcare compliance program management, will showcase a range ... and National Association for Assisted Living (NCAL) Convention and Expo to be held ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of ... announced today its plans to open a flagship location in Covington, LA at 401 ... Rooms To Go store next to Office Depot in the Holiday Square shopping center. ...
(Date:10/12/2017)... CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... cold therapy products, announced today the introduction of an innovative new design of the ... multipurpose pad so you get maximum comfort while controlling your pain while using cold ...
(Date:10/12/2017)... ... 12, 2017 , ... Asante, a nationally recognized health system ... their existing home health joint venture through an agreement, effective October 1, 2017, ... venture home health company with Asante, delivering clinically integrated care, for the past ...
(Date:10/12/2017)... ... 12, 2017 , ... Dr. Parsa Mohebi, the Los Angeles ... to the newly revamped Cosmetic Town journal section, featuring articles written ... known as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I ...
Breaking Medicine News(10 mins):